QL Biopharm Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 188

Employees

  • Latest Deal Type
  • Series C1

  • Financing Rounds
  • 14

QL Biopharm General Information

Description

Developer of peptide therapeutics and metabolic disease treatments designed for the management of obesity and related metabolic disorders. The company's pipeline includes monthly injectable GLP-1 receptor agonists, oral peptide therapies, and multi-target drug candidates, supported by proprietary peptide engineering and GMP-compliant manufacturing facilities, enabling patients with metabolic conditions to access differentiated and personalized therapeutic options.

Contact Information

Website
www.qlbiopharm.com
Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Corporate Office
  • No. 101, Building 7, 20 Life Science Park Road
  • Changping District
  • Beijing, 102206
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • No. 101, Building 7, 20 Life Science Park Road
  • Changping District
  • Beijing, 102206
  • China
+86 010

QL Biopharm Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QL Biopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QL Biopharm‘s full profile, request access.

Request a free trial

QL Biopharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QL Biopharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore QL Biopharm‘s full profile, request access.

Request a free trial

QL Biopharm FAQs

  • When was QL Biopharm founded?

    QL Biopharm was founded in 2018.

  • Where is QL Biopharm headquartered?

    QL Biopharm is headquartered in Beijing, China.

  • What is the size of QL Biopharm?

    QL Biopharm has 188 total employees.

  • What industry is QL Biopharm in?

    QL Biopharm’s primary industry is Drug Discovery.

  • Is QL Biopharm a private or public company?

    QL Biopharm is a Private company.

  • What is QL Biopharm’s current revenue?

    The current revenue for QL Biopharm is .

  • How much funding has QL Biopharm raised over time?

    QL Biopharm has raised $220M.

  • Who are QL Biopharm’s investors?

    Cathay Capital, Huatai Zijin Investment, Huagai Capital, 5Y Capital, and Apricot Capital (Shanghai) are 5 of 27 investors who have invested in QL Biopharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process